These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 18180373

  • 41. Inhibition of Galphaq-dependent PLC-beta1 activity by PKG and PKA is mediated by phosphorylation of RGS4 and GRK2.
    Huang J, Zhou H, Mahavadi S, Sriwai W, Murthy KS.
    Am J Physiol Cell Physiol; 2007 Jan; 292(1):C200-8. PubMed ID: 16885398
    [Abstract] [Full Text] [Related]

  • 42. Gastric motility in soluble guanylate cyclase alpha 1 knock-out mice.
    Vanneste G, Dhaese I, Sips P, Buys E, Brouckaert P, Lefebvre RA.
    J Physiol; 2007 Nov 01; 584(Pt 3):907-20. PubMed ID: 17717014
    [Abstract] [Full Text] [Related]

  • 43. Phosphodiesterase 3A expression is modulated by nitric oxide in rat pulmonary artery smooth muscle cells.
    Busch CJ, Graveline AR, Jiramongkolchai K, Liu H, Sanchez LS, Bloch KD.
    J Physiol Pharmacol; 2010 Dec 01; 61(6):663-9. PubMed ID: 21224496
    [Abstract] [Full Text] [Related]

  • 44. Soluble guanylate cyclase modulators blunt hyperoxia effects on calcium responses of developing human airway smooth muscle.
    Britt RD, Thompson MA, Kuipers I, Stewart A, Vogel ER, Thu J, Martin RJ, Pabelick CM, Prakash YS.
    Am J Physiol Lung Cell Mol Physiol; 2015 Sep 15; 309(6):L537-42. PubMed ID: 26254425
    [Abstract] [Full Text] [Related]

  • 45. Interaction between the 90-kDa heat shock protein and soluble guanylyl cyclase: physiological significance and mapping of the domains mediating binding.
    Papapetropoulos A, Zhou Z, Gerassimou C, Yetik G, Venema RC, Roussos C, Sessa WC, Catravas JD.
    Mol Pharmacol; 2005 Oct 15; 68(4):1133-41. PubMed ID: 16024662
    [Abstract] [Full Text] [Related]

  • 46. An evolutionarily conserved mechanism for sensitization of soluble guanylyl cyclase reveals extensive nitric oxide-mediated upregulation of cyclic GMP in insect brain.
    Ott SR, Delago A, Elphick MR.
    Eur J Neurosci; 2004 Sep 15; 20(5):1231-44. PubMed ID: 15341595
    [Abstract] [Full Text] [Related]

  • 47. Structure/activity relationships of (M)ANT- and TNP-nucleotides for inhibition of rat soluble guanylyl cyclase α1β1.
    Dove S, Danker KY, Stasch JP, Kaever V, Seifert R.
    Mol Pharmacol; 2014 Apr 15; 85(4):598-607. PubMed ID: 24470063
    [Abstract] [Full Text] [Related]

  • 48. Effects of 5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine (BAY 41-2272) on smooth muscle tone, soluble guanylyl cyclase activity, and NADPH oxidase activity/expression in corpus cavernosum from wild-type, neuronal, and endothelial nitric-oxide synthase null mice.
    Teixeira CE, Priviero FB, Webb RC.
    J Pharmacol Exp Ther; 2007 Sep 15; 322(3):1093-102. PubMed ID: 17596536
    [Abstract] [Full Text] [Related]

  • 49. Cross-regulation of VPAC(2) receptor desensitization by M(3) receptors via PKC-mediated phosphorylation of RKIP and inhibition of GRK2.
    Huang J, Mahavadi S, Sriwai W, Grider JR, Murthy KS.
    Am J Physiol Gastrointest Liver Physiol; 2007 Mar 15; 292(3):G867-74. PubMed ID: 17170028
    [Abstract] [Full Text] [Related]

  • 50. Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation.
    Sayed N, Baskaran P, Ma X, van den Akker F, Beuve A.
    Proc Natl Acad Sci U S A; 2007 Jul 24; 104(30):12312-7. PubMed ID: 17636120
    [Abstract] [Full Text] [Related]

  • 51. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP, Drejer J, Axelsson O, Moldt P, Bang L, Nielsen-Kudsk JE, Busse R, Mülsch A.
    Br J Pharmacol; 1998 Jan 24; 123(2):299-309. PubMed ID: 9489619
    [Abstract] [Full Text] [Related]

  • 52. Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in rats.
    Jabs A, Oelze M, Mikhed Y, Stamm P, Kröller-Schön S, Welschof P, Jansen T, Hausding M, Kopp M, Steven S, Schulz E, Stasch JP, Münzel T, Daiber A.
    Vascul Pharmacol; 2015 Aug 24; 71():181-91. PubMed ID: 25869522
    [Abstract] [Full Text] [Related]

  • 53. The receptor-like properties of nitric oxide-activated soluble guanylyl cyclase in intact cells.
    Bellamy TC, Garthwaite J.
    Mol Cell Biochem; 2002 Jan 24; 230(1-2):165-76. PubMed ID: 11952092
    [Abstract] [Full Text] [Related]

  • 54. YC-1 stimulates the expression of gaseous monoxide-generating enzymes in vascular smooth muscle cells.
    Liu XM, Peyton KJ, Mendelev NN, Wang H, Tulis DA, Durante W.
    Mol Pharmacol; 2009 Jan 24; 75(1):208-17. PubMed ID: 18923065
    [Abstract] [Full Text] [Related]

  • 55. The soluble guanylyl cyclase activator YC-1 increases intracellular cGMP and cAMP via independent mechanisms in INS-1E cells.
    Ramos-Espiritu LS, Hess KC, Buck J, Levin LR.
    J Pharmacol Exp Ther; 2011 Sep 24; 338(3):925-31. PubMed ID: 21665942
    [Abstract] [Full Text] [Related]

  • 56. Spontaneous and receptor-controlled soluble guanylyl cyclase activity in anterior pituitary cells.
    Kostic TS, Andric SA, Stojilkovic SS.
    Mol Endocrinol; 2001 Jun 24; 15(6):1010-22. PubMed ID: 11376118
    [Abstract] [Full Text] [Related]

  • 57. Synthesis and evaluation of a phosphonate analogue of the soluble guanylate cyclase activator YC-1.
    Martin NI, Derbyshire ER, Marletta MA.
    Bioorg Med Chem Lett; 2007 Sep 01; 17(17):4938-41. PubMed ID: 17587571
    [Abstract] [Full Text] [Related]

  • 58. High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria.
    Wen JF, Cui X, Jin JY, Kim SM, Kim SZ, Kim SH, Lee HS, Cho KW.
    Circ Res; 2004 Apr 16; 94(7):936-43. PubMed ID: 14988225
    [Abstract] [Full Text] [Related]

  • 59. Activation of particulate guanylyl cyclase by endothelins in cultured SV-40 transformed cat iris sphincter smooth muscle cells.
    Ding KH, Latimer AJ, Abdel-Latif AA.
    Life Sci; 1999 Apr 16; 64(3):161-74. PubMed ID: 10027747
    [Abstract] [Full Text] [Related]

  • 60. Prostacyclin receptor-induced STAT3 phosphorylation in human erythroleukemia cells is mediated via Galpha(s) and Galpha(16) hybrid signaling.
    Lo RK, Liu AM, Wise H, Wong YH.
    Cell Signal; 2008 Nov 16; 20(11):2095-106. PubMed ID: 18755267
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.